Virtus ETF Advisers LLC Esperion Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

  • $206 Million
  • Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 113,178 shares of ESPR stock, worth $239,937. This represents 0.09% of its overall portfolio holdings.

Number of Shares
113,178
Previous 113,178 -0.0%
Holding current value
$239,937
Previous $251,000 25.9%
% of portfolio
0.09%
Previous 0.13%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.84 - $3.24 $208,247 - $366,696
113,178 New
113,178 $251,000
Q4 2021

Feb 14, 2022
SELL
$4.81 - $11.92 $85,488 - $211,854
-17,773 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$11.34 - $21.37 $18,427 - $34,726
-1,625 Reduced 8.38%
17,773 $214,000
Q2 2021

Aug 10, 2021
SELL
$19.4 - $28.71 $34,124 - $50,500
-1,759 Reduced 8.31%
19,398 $410,000
Q1 2021

May 17, 2021
BUY
$25.12 - $36.89 $14,594 - $21,433
581 Added 2.82%
21,157 $593,000
Q4 2020

Feb 12, 2021
BUY
$24.2 - $35.76 $172,642 - $255,111
7,134 Added 53.07%
20,576 $535,000
Q3 2020

Nov 13, 2020
BUY
$31.18 - $52.71 $35,295 - $59,667
1,132 Added 9.2%
13,442 $500,000
Q2 2020

Aug 05, 2020
BUY
$30.04 - $51.31 $152,453 - $260,398
5,075 Added 70.15%
12,310 $632,000
Q1 2020

May 14, 2020
SELL
$27.44 - $73.84 $29,168 - $78,491
-1,063 Reduced 12.81%
7,235 $228,000
Q4 2019

Feb 13, 2020
BUY
$35.4 - $59.82 $111,651 - $188,672
3,154 Added 61.31%
8,298 $495,000
Q3 2019

Nov 12, 2019
SELL
$34.47 - $47.53 $9,858 - $13,593
-286 Reduced 5.27%
5,144 $189,000
Q2 2019

Aug 13, 2019
SELL
$40.1 - $52.33 $2,125 - $2,773
-53 Reduced 0.97%
5,430 $253,000
Q1 2019

May 14, 2019
SELL
$40.11 - $53.57 $31,927 - $42,641
-796 Reduced 12.68%
5,483 $220,000
Q4 2018

Feb 05, 2019
SELL
$36.99 - $59.11 $185,615 - $296,613
-5,018 Reduced 44.42%
6,279 $289,000
Q3 2018

Nov 14, 2018
SELL
$40.74 - $51.41 $333,538 - $420,893
-8,187 Reduced 42.02%
11,297 $501,000
Q2 2018

Aug 10, 2018
BUY
$36.2 - $76.4 $236,784 - $499,732
6,541 Added 50.54%
19,484 $764,000
Q1 2018

May 14, 2018
BUY
$65.94 - $80.76 $454,062 - $556,113
6,886 Added 113.69%
12,943 $936,000
Q4 2017

Feb 14, 2018
SELL
$43.47 - $67.43 $138,799 - $215,303
-3,193 Reduced 34.52%
6,057 $399,000
Q3 2017

Nov 14, 2017
BUY
$43.8 - $52.77 $37,054 - $44,643
846 Added 10.07%
9,250 $464,000
Q2 2017

Aug 14, 2017
BUY
N/A
8,404
8,404 $389,000

Others Institutions Holding ESPR

# of Institutions
208
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $141M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email